Title : FLAP inhibitors for the treatment of inflammatory diseases.

Pub. Date : 2009 Nov

PMID : 19876784






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Leukotriene synthesis requires 5-lipoxygenase activating protein (FLAP), which acts as a scaffolding protein for the assembly of other enzymes involved in the leukotriene synthetic pathway occurring at the nuclear envelope of leukocytes. Leukotrienes arachidonate 5-lipoxygenase activating protein Homo sapiens
2 Leukotriene synthesis requires 5-lipoxygenase activating protein (FLAP), which acts as a scaffolding protein for the assembly of other enzymes involved in the leukotriene synthetic pathway occurring at the nuclear envelope of leukocytes. Leukotrienes arachidonate 5-lipoxygenase activating protein Homo sapiens
3 By blocking the formation of both leukotriene B4 and the cysteinyl leukotrienes (ie, LTC4 , LTD4 and LTE4), FLAP inhibitors act as broad-spectrum leukotriene-modifier drugs that may have a wide range of therapeutic applications. Leukotrienes arachidonate 5-lipoxygenase activating protein Homo sapiens